BlackRock Fund Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$22.2M Buy
1,132,907
+255,215
+29% +$4.63M ﹤0.01% 2124
2016
Q3
$13.9M Buy
877,692
+60,058
+7% +$923K ﹤0.01% 2265
2016
Q2
$11.6M Buy
817,634
+87,089
+12% +$1.33M ﹤0.01% 2321
2016
Q1
$12.3M Sell
730,545
-33,543
-4% -$590K ﹤0.01% 2252
2015
Q4
$17.1M Buy
764,088
+26,360
+4% +$543K ﹤0.01% 2135
2015
Q3
$16.2M Sell
737,728
-5,438
-0.7% -$136K ﹤0.01% 2129
2015
Q2
$18.3M Sell
743,166
-18,077
-2% -$404K ﹤0.01% 2167
2015
Q1
$15.6M Sell
761,243
-1,105
-0.1% -$21.4K ﹤0.01% 2200
2014
Q4
$15.2M Buy
762,348
+98,566
+15% +$1.69M ﹤0.01% 2218
2014
Q3
$9.77M Sell
663,782
-17,686
-3% -$282K ﹤0.01% 2361
2014
Q2
$12.5M Buy
681,468
+2,340
+0.3% +$38.9K ﹤0.01% 2284
2014
Q1
$12.8M Buy
679,128
+113,428
+20% +$2.32M ﹤0.01% 2254
2013
Q4
$10.6M Sell
565,700
-24,754
-4% -$360K ﹤0.01% 2358
2013
Q3
$6.48M Buy
590,454
+68,576
+13% +$676K ﹤0.01% 2618
2013
Q2
$4.96M Buy
+521,878
New +$4.55M ﹤0.01% 2689

Other funds holding ATRC

BlackRock Fund Advisors's ATRC Position: Q4 2016 in Review

BlackRock Fund Advisors increased its AtriCure (ATRC) stake by 29% in Q4 2016, buying an estimated $4.63M and bringing the position to 1,132,907 shares worth $22.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2124.

BlackRock Fund Advisors first reported a position in ATRC in Q2 2013 and has held it in 15 quarters since. 100 funds tracked by Wall St. Rank hold ATRC as of Q4 2016.

  • BlackRock Fund Advisors held 1,132,907 shares of AtriCure worth $22.2M as of Q4 2016.
  • BlackRock Fund Advisors bought 255,215 AtriCure shares in Q4 2016, an estimated $4.63M.
  • AtriCure made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2124 holding.
  • BlackRock Fund Advisors first reported a position in AtriCure in Q2 2013 and has held it in 15 quarters since.
  • 100 funds tracked by Wall St. Rank held AtriCure as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.